Enter multiple symbols separated by commas

BioCryst Wins Flu Drug Contract, Stock Jumps More Than 10%

The Department of Health and Human Services said it has awarded a $102.6 million, four-year contract to BioCryst Pharmaceuticals for advanced development of its influenza antiviral drug, peramivir. BioCryst shares soared on the news, trading as high as $12.50 -- a 12% gain over yesterday's closing price.

In laboratory studies to date, peramivir has shown effectiveness against a number of influenza strains, the department said in a statement.

HHS added that funding provided under the new contract will support further studies to determine if peramivir can be an effective treatment for seasonal and life-threatening influenza.

Contact U.S. News


    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • Hero miles for military members: Real estate magnate's plea

    Chairman of the Fisher House Foundation, Ken Fisher, discusses the Hero Miles program with CNBC's Dina Gusovsky. During Military Appreciation Month, Fisher is asking every traveler to donate 1,000 of their miles to replenish the Hero Miles programs that is in danger of running out.

  • Cramer shuts down this market's haters

    "Mad Money" host Jim Cramer on why this market can't stop, won't stop.

  • From the battlefield to the boardroom

    Your Grateful Nation is dedicated to helping Special Forces veterans enter the corporate world and Knot Standard provides complimentary suits to vets. Mad Money's Jim Cramer spoke with Rob Clapper, Your Grateful executive director; John Ballay, Knot Standard co-founder and president; Tej Gill, retired U.S. Navy Seal; and Darren McB, active duty U.S. Navy Seal.